Mechanism of B cell proliferation and diffentiation in peripheral lymphoid organs

外周淋巴器官B细胞增殖和分化的机制

基本信息

项目摘要

B cell development in peripheral lymphoid organs requires an intimate interaction with follicular dendritic cells (FDC). FDC provides antigens, chemokines, and cyokines, which support B cell growth and differentiation. Then, transcriptional machinery including NF-kappaB is activated. This study aims to clarify these steps in vivo mainly by using gene targeting approach.1. FDC produces a chemokine, BLC, which is known to act on mature B cells in vitro. In order to clarify its in vivo roles, we have established BLC-deficient mice. BLC-deficient mice were born healthy. We plan to analyze B cell distribution in peripheral lymphoid organs, FDC differentiation, and immune responses in BLC-deficient mice.2. Both IkappaB kinase (IKK) alpha and beta activate NF-kappaB activities, which are critical for B cell growth and differentiation. Although these two kinases shows similar molecular structures and functions, they are differentially required for various tissues. IKKalpha-deficient mice die soon after birth because of limb and epidermis malformation. In order to analyze how IKKalpha plays critical roles in B cells, we have established IKKalpha-deficient chimeric mice by transferring IKKalpha-deficient fetal liver cells into irradiated mice. IKKalpha-deficient chimeras showed decrease of mature B cell population mainly through enhanced apoptosis. They also showed severe impairment of immunoglobulin production and immune response. The results suggest that IKKalpha is essential for B cell growth and differentiation in peripheral lymphoid organs and that IKKbeta alone cannot properly activate NF-kappaB in mature B cells.3. We have established the mutant mice lacking a transcription factor, C/EBPgamma. C/EBPgamma-deficient natural killer (NK) cells showed impairment of NK activity and interferon-gamma production. Novel gene(s) were assumed to be involved in C/EBPgamma-mediated NK activity. Identification of the target gene of C/EBPgamma is now in progress.
外周淋巴器官中的B细胞发育需要与滤泡树突状细胞(FDC)的密切相互作用。FDC提供支持B细胞生长和分化的抗原、趋化因子和细胞因子。然后,包括NF-κ B的转录机制被激活。本研究主要通过基因打靶的方法在体内阐明这些步骤. FDC产生一种趋化因子BLC,已知其在体外作用于成熟B细胞。为了阐明其在体内的作用,我们建立了BLC缺陷小鼠。BLC缺陷小鼠出生时健康。我们计划分析BLC缺陷小鼠外周淋巴器官中B细胞的分布、FDC分化和免疫应答. I κ B激酶(IKK)α和β均激活NF-κ B活性,这对B细胞生长和分化至关重要。虽然这两种激酶显示出相似的分子结构和功能,但它们对各种组织的需求不同。IKKalalpha缺陷小鼠出生后很快死亡,因为肢体和表皮畸形。为了分析IKK α如何在B细胞中发挥关键作用,我们通过将IKK α缺陷型胎肝细胞转移到辐射小鼠中来建立IKK α缺陷型嵌合小鼠。IKKalalpha缺陷型嵌合体显示成熟B细胞群减少,主要通过增强凋亡。他们还表现出严重的免疫球蛋白产生和免疫反应受损。结果表明IKK α对外周淋巴器官中B细胞的生长和分化是必不可少的,IKK β单独不能正确激活成熟B细胞中的NF-κ B.我们已经建立了缺乏转录因子C/EBP γ的突变小鼠。C/EBP γ缺陷型自然杀伤(NK)细胞表现出NK活性和干扰素γ产生的损害。新基因被认为参与C/EBP γ介导的NK活性。C/EBP γ的靶基因鉴定正在进行中。

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
H.Akaishi,et al.: "Defective IL-2-mediated IL2 receptor a chain expression in Stat3-deficient T lymphocytes." Int.Immunol.10. 1747-1751 (1998)
H.Akaishi 等人:“Stat3 缺陷 T 淋巴细胞中缺陷性 IL-2 介导的 IL2 受体 a 链表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kaisho T.: "Impairment of natural killer cytotoxic activity and interferon-γ production in C/EBPγ-deficient mice."J. Exp. Med.. 190. 1573-1581 (1999)
Kaisho T.:“C/EBPγ 缺陷小鼠中自然杀伤细胞毒性活性和干扰素 γ 产生的损害。”J. Exp. 190. 1573-1581 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Kaisho: "Impairment of natural killer cytotoxic activity and interferon-γ production in C/EBP γ-deficient mice"Journal of Experimental Medicine. 190. 1573-1581 (1999)
T. Kaisho:“C/EBP γ 缺陷小鼠中自然杀伤细胞毒性活性和干扰素 γ 产生的损害”实验医学杂志 190. 1573-1581 (1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Takeda, et al.: "Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils." Immunity. 10. 39-49 (1999)
K.Takeda 等人:“在巨噬细胞和中性粒细胞中缺乏 Stat3 的小鼠中,Th1 活性增强并促进慢性小肠结肠炎的发展。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K. Takeda: "Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils"Immunity. 10. 39-49 (1999)
K. Takeda:“在巨噬细胞和中性粒细胞中缺乏 Stat3 的小鼠中增强 Th1 活性并促进慢性小肠结肠炎的发展”免疫。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAISHO Tsuneyasu其他文献

KAISHO Tsuneyasu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAISHO Tsuneyasu', 18)}}的其他基金

Elucidation of behavior and functions of a dendritic cell subset with high crosspresenting activity
阐明具有高交叉呈递活性的树突状细胞亚群的行为和功能
  • 批准号:
    23659245
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Clarification of molecular mechanisms for regulating dendritic cell subset functions
阐明调节树突状细胞亚群功能的分子机制
  • 批准号:
    23390124
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanisms for type I interferon production by Toll-like receptor-stimulated dendritic cells
Toll样受体刺激树突状细胞产生I型干扰素的分子机制
  • 批准号:
    20390146
  • 财政年份:
    2008
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Dendritic cell activation mechanisms by nucleic by nucleic acid immune adjuvants.
核酸免疫佐剂通过核酸激活树突状细胞的机制。
  • 批准号:
    18590483
  • 财政年份:
    2006
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of novel immune adjuvants and their acting mechanism on dendritic cell function
新型免疫佐剂的鉴定及其对树突状细胞功能的作用机制
  • 批准号:
    16590403
  • 财政年份:
    2004
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dendritic cell activation mechanism by Toll-like receptors
Toll样受体的树突状细胞激活机制
  • 批准号:
    14570280
  • 财政年份:
    2002
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of NK cell dysfunction in C/EBP-γ deficient mice
C/EBP-γ缺陷小鼠NK细胞功能障碍的机制
  • 批准号:
    12670304
  • 财政年份:
    2000
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

Consequences of MALT1 mutation for B cell tolerance
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
  • 批准号:
    502607
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
RNA helicases; switched paralogue dependency as an exploitable vulnerability in aggressive B cell lymphoma.
RNA解旋酶;
  • 批准号:
    EP/Y030303/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Research Grant
Roles of immune cells derived from clonal hematopoiesis in B-cell lymphomas
克隆造血来源的免疫细胞在 B 细胞淋巴瘤中的作用
  • 批准号:
    24K19213
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
B cell development, autoimmunity and immune regulation
B 细胞发育、自身免疫和免疫调节
  • 批准号:
    MR/Y033701/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Research Grant
Cellular dynamics in chronic lung disease: the neglected B cell axis
慢性肺病的细胞动力学:被忽视的 B 细胞轴
  • 批准号:
    MR/X03383X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Fellowship
Exploration of T- and B-cell receptors to eliminate the foreign body reaction from synthetic polymeric scaffolds
探索 T 细胞和 B 细胞受体以消除合成聚合物支架的异物反应
  • 批准号:
    24K19917
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Chromatin-binding deubiquitinase MYSM1 as a putative drug target for cMYC-driven B cell lymphoma
染色质结合去泛素酶 MYSM1 作为 cMYC 驱动的 B 细胞淋巴瘤的推定药物靶点
  • 批准号:
    478278
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Operating Grants
Artificial Intelligence analysis of the immune-checkpoint and immuno-oncology in B-cell non-Hodgkin lymphoma
B 细胞非霍奇金淋巴瘤免疫检查点和免疫肿瘤学的人工智能分析
  • 批准号:
    23K06454
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Research Grant
Identification of pathogenesis-promoting interferon-stimulated genes and development of regulatory strategies in mature B-cell tumors
成熟 B 细胞肿瘤中干扰素刺激促进发病基因的鉴定和调控策略的开发
  • 批准号:
    23K15330
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了